To investigate the potential prognostic value of MPZL3 in cancers, we integrated the MPZL3 mRNA expression level with the overall survival (OS), progression-free interval (PFI), disease-specific survival (DSS) and disease-free survival (DFI) of the 33 cancer types in the TCGA database. The gene discussed is MPZL3; the disease is cancer.